Cargando…
Valproic acid sensitizes pancreatic cancer cells to natural killer cell-mediated lysis by upregulating MICA and MICB via the PI3K/Akt signaling pathway
BACKGROUND: Valproic acid (VPA), a histone deacetylase (HDAC) inhibitor, is reported to exert anti-tumor effects by upregulating the expression of the natural killer group 2D (NKG2D) ligands on tumor cells; however, the mechanisms vary in different tumor types, and the effect and mechanism of action...
Autores principales: | Shi, Pengfei, Yin, Tao, Zhou, Feng, Cui, Pengfei, Gou, Shanmiao, Wang, Chunyou |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4076062/ https://www.ncbi.nlm.nih.gov/pubmed/24885711 http://dx.doi.org/10.1186/1471-2407-14-370 |
Ejemplares similares
-
Dendritic Cells Loaded with Pancreatic Cancer Stem Cells (CSCs) Lysates Induce Antitumor Immune Killing Effect In Vitro
por: Yin, Tao, et al.
Publicado: (2014) -
Low Concentrations of Metformin Selectively Inhibit CD133(+) Cell Proliferation in Pancreatic Cancer and Have Anticancer Action
por: Gou, Shanmiao, et al.
Publicado: (2013) -
Association of MICA and MICB polymorphisms with the susceptibility of leukemia in Korean patients
por: Baek, In-Cheol, et al.
Publicado: (2018) -
Expression of MICA, MICB and NKG2D in human leukemic myelomonocytic and cervical cancer cells
por: Weiss-Steider, Benny, et al.
Publicado: (2011) -
Decreased Dicer expression elicits DNA damage and up-regulation of MICA and MICB
por: Tang, Kai-Fu, et al.
Publicado: (2008)